digests, results were visualized by ethidium bromide staining under ultraviolet illumination. Genotype distributions were analysed using )(statistic throughout, with a probability of less than 5% indicating statistical significance.
The overall frequencies of the apolipoprotein f2, f3 and f4 alleles in the epilepsy patients were no different to those of the control group (Table 1) . Subgroups consisting of patients with either an unknown aetiology for epilepsy (71% of patients), a family history of epilepsy (21% of patients), idiopathic generalized epilepsy, or cryptogenic partial seizures showed no significant difference in allele frequency when compared with controls. Likewise, the age of onset of epilepsy was no f4 allele frequency d allele frequency
£2 allele frequency
The aetiology of epilepsy is often multifactorial with 60-700/0 of all cases having no clear cause. Although much is known about the physiological basis of the abnormal discharges accompanying seizure phenomena, the cellular mechanisms responsible for epileptogenesis remain conjectural. It seems likely that there is a primary defect in the neuronal membrane that results in an instability of the resting membrane potential.'
Apolipoprotein E is unique among apolipoproteins in having a special relevance to nervous tissue.? It is involved in the mobilization of cholesterol in repair, growth and maintenance of myelin and neuronal membranes during development or after injury.3-5 An increased frequency of the apolipoprotein f4 allele has been observed in patients with chronic neurological conditions such as Alzheimer's disease," and dementia in Parkinson's disease," Therefore, this study has sought to establish if such an association exists in patients with seizure disorders.
Additional key phrases: seizure disorders; apolipoprotein genotypes; Alzheimer's disease PATIENTS AND METHODS A total of 312 patients (149 male, 163 female, median age 32 years, range 13-83) with epilepsy were recruited from the Epilepsy Clinic, Western Infirmary, Glasgow, Scotland. Their aetiology, age of onset of epilepsy and seizure type were recorded together with any family history of epilepsy or Alzheimer's disease. A control group of 241 individuals were also included. Apolipoprotein E polymorphisms were determined using standard polymerase chain reaction (PCR) techniques followed by restriction enzyme digestion with the Cfol endonuclease. There is evidence that up to 270/0 of epileptic seizures is related to genetic variability. 9 However, little progress has been made in mapping the genetics for the majority of seizure disorders. This contrasts with Alzheimer's disease (in which epilepsycan be a late feature), where a study of 500 sporadic cases found that at least one copy of the apolipoprotein f4 allele was present in 64% of patients compared to 31% of controls." However, in spite of its influence on neuronal membrane structure, this present study has shown that apolipoprotein E polymorphism has no association with the development ofthe major seizuredisorders.
